Works matching DE "HERPES zoster vaccines"
Results: 770
The Shingles National Immunisation Programme: a comprehensive guide.
- Published in:
- Practice Nursing, 2025, v. 36, n. Sup2, p. 1, doi. 10.12968/pnur.2025.36.Sup2.S1
- Publication type:
- Article
Longitudinal single cell profiling of epitope specific memory CD4+ T cell responses to recombinant zoster vaccine.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-57562-7
- By:
- Publication type:
- Article
Effect of herpes zoster vaccine on patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
- Published in:
- Virology Journal, 2025, v. 22, n. 1, p. 1, doi. 10.1186/s12985-025-02670-5
- By:
- Publication type:
- Article
Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine.
- Published in:
- Pathogens, 2025, v. 14, n. 2, p. 195, doi. 10.3390/pathogens14020195
- By:
- Publication type:
- Article
An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy.
- Published in:
- Pathogens, 2025, v. 14, n. 2, p. 145, doi. 10.3390/pathogens14020145
- By:
- Publication type:
- Article
Herpes zoster prevention in multiple sclerosis and neuromyelitis optica spectrum disorders.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2025, v. 59, n. 1, p. 1, doi. 10.5603/pjnns.102908
- By:
- Publication type:
- Article
The introduction of a new preventive vaccine for shingles.
- Published in:
- Practice Nursing, 2013, v. 24, n. 11, p. 550, doi. 10.12968/pnur.2013.24.11.550
- By:
- Publication type:
- Article
Expanding the coverage of herpes zoster vaccination recommendations in European countries: the example of Portugal: Expanding the coverage of herpes zoster vaccination recommendations in Europe: S. Duque et al.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 34, doi. 10.1007/s40267-024-01126-0
- By:
- Publication type:
- Article
Herpes Zoster Ophthalmicus: A Teaching Case Report.
- Published in:
- Optometric Education, 2014, v. 39, n. 2, p. 65
- By:
- Publication type:
- Article
Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 8, p. 2503, doi. 10.1007/s10067-024-07041-z
- By:
- Publication type:
- Article
Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 6, p. 2133, doi. 10.1007/s10067-024-06980-x
- By:
- Publication type:
- Article
Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 6, p. 1659, doi. 10.1007/s10067-022-06096-0
- By:
- Publication type:
- Article
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Notes from the Field: Hospital Contact Investigation for a Patient Who Developed a Zoster Vaccine-Related Rash - Maryland, February 2015.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hospital Contact Investigation for a Patient Who Developed a Zoster Vaccine-Related Rash -- Maryland, February 2015.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2017, v. 66, n. 28, p. 763, doi. 10.15585/mmwr.mm6628a6
- By:
- Publication type:
- Article
Update on Recommendations for Use of Herpes Zoster Vaccine.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2014, v. 63, n. 33, p. 729
- By:
- Publication type:
- Article
Noninfluenza Vaccination Coverage Among Adults -- United States, 2012.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2014, v. 63, n. 5, p. 95
- By:
- Publication type:
- Article
Noninfluenza Vaccination Coverage Among Adults -- United States, 2011.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2013, v. 62, n. 4, p. 66
- By:
- Publication type:
- Article
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00467-z
- By:
- Publication type:
- Article
Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report.
- Published in:
- Oxford Medical Case Reports, 2022, v. 2022, n. 12, p. 1, doi. 10.1093/omcr/omac134
- By:
- Publication type:
- Article
Prevention and management of shingles and associated complications.
- Published in:
- Journal of Community Nursing, 2018, v. 32, n. 6, p. 40
- By:
- Publication type:
- Article
How to identify and treat herpes zoster (shingles).
- Published in:
- Journal of Community Nursing, 2014, v. 28, n. 6, p. 59
- By:
- Publication type:
- Article
Preventive Medicine in Chronic Pain: The Role of Shingrix<sup>®</sup> Vaccine for the Prevention of Postherpetic Neuralgia.
- Published in:
- 2025
- By:
- Publication type:
- Letter
In brief.
- Published in:
- Nursing Older People, 2013, v. 25, n. 7, p. 6
- Publication type:
- Article
Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1447, doi. 10.1007/s13555-022-00744-8
- By:
- Publication type:
- Article
Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older.
- Published in:
- Dermatology & Therapy, 2019, v. 9, n. 2, p. 281, doi. 10.1007/s13555-019-0291-4
- By:
- Publication type:
- Article
The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis.
- Published in:
- Dermatology & Therapy, 2018, v. 8, n. 2, p. 269, doi. 10.1007/s13555-018-0236-3
- By:
- Publication type:
- Article
Vaccination Across the Lifespan: A Public Health Imperative.
- Published in:
- Annals of King Edward Medical University, 2024, v. 30, n. 3, p. 221, doi. 10.21649/akemu.v30i3.5843
- By:
- Publication type:
- Article
Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 7, p. 739, doi. 10.3390/biom14070739
- By:
- Publication type:
- Article
Adult Immunization in Patients with Diabetes Mellitus: Current Immunization Status and Recommended Schedule in Korea.
- Published in:
- Journal of Korean Diabetes, 2013, v. 14, n. 3, p. 103, doi. 10.4093/jkd.2013.14.3.103
- By:
- Publication type:
- Article
Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 8, p. 1094, doi. 10.1111/dme.13038
- By:
- Publication type:
- Article
Vaccination in patients with chronic kidney disease—Review of current recommendations and recent advances.
- Published in:
- Nephrology, 2021, v. 26, n. 1, p. 5, doi. 10.1111/nep.13741
- By:
- Publication type:
- Article
Herpes zoster and Alzheimer's disease.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2022, v. 272, n. 5, p. 923, doi. 10.1007/s00406-021-01311-6
- By:
- Publication type:
- Article
Vaccine-Associated Uveitis.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Herpes Zoster Keratouveitis and Inflammatory Ocular Hypertension 8 Years After Varicella Vaccination.
- Published in:
- Ocular Immunology & Inflammation, 2009, v. 17, n. 1, p. 33, doi. 10.1080/09273940802491892
- By:
- Publication type:
- Article
Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost Effectiveness of Herpes Zoster Vaccine in Canada.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 12, p. 991, doi. 10.2165/11314010-000000000-00000
- By:
- Publication type:
- Article
Improving Adult Immunization Practices Using a Team Approach in the Primary Care Setting.
- Published in:
- American Journal of Public Health, 2012, v. 102, n. 7, p. e46, doi. 10.2105/AJPH.2012.300665
- By:
- Publication type:
- Article
Postherpetic Neuralgia After Herpes Zoster Vaccination.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 1, p. 43, doi. 10.1001/jama.2012.7304
- By:
- Publication type:
- Article
Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 Through 59 Years.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 307, n. 2, p. 137
- By:
- Publication type:
- Article
FDA Expands Age Range for Shingles Vaccine.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 305, n. 15, p. 1526, doi. 10.1001/jama.2011.495
- By:
- Publication type:
- Article
Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 2, p. 189, doi. 10.7326/M23-2023
- By:
- Publication type:
- Article
Major Update 2: Antibody Response and Risk for Reinfection After SARS-CoV-2 Infection-Final Update of a Living, Rapid Review.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 1, p. 85, doi. 10.7326/M22-1745
- By:
- Publication type:
- Article
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction: Recommended Adult Immunization Schedule, United States, 2019.
- Published in:
- 2019
- Publication type:
- journal article
Prevention of Shingles: Better Protection and Better Value With Recombinant Vaccine.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Review: Adjuvant recombinant subunit vaccine prevents herpes zoster more than live attenuated vaccine in adults ≥ 50 years.
- Published in:
- Annals of Internal Medicine, 2019, v. 170, n. 4, p. JC14, doi. 10.7326/ACPJ201902190-014
- By:
- Publication type:
- Article
In the Clinic®. Herpes Zoster.
- Published in:
- 2018
- By:
- Publication type:
- journal article